DNAVision

DNAVision is a leading European contract research organization specializing in applied genomic services. Based in Belgium and founded as a spin-off from the University of Liège, the company provides high-quality genetic analysis for the pharmaceutical, biotechnology, and agrifood sectors. Their core competencies include next-generation sequencing (NGS), genotyping, and gene expression profiling, often performed under GLP and GCP standards. DNAVision plays a critical role in drug development by offering pharmacogenomic testing and clinical trial support. In 2016, the company was acquired by Eurofins Scientific, integrating its expertise into Eurofins' global genomics division. Today, it continues to serve as a center of excellence for complex genomic projects and regulated genetic testing.